Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

about

Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.

P2860

Q38660842-C257464C-AEF5-4CE9-977A-20280BDEA200

P2860

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

Item

http://www.wikidata.org/entity/Q45342736

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@en

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@nl

type

Item

label

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@en

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@nl

prefLabel

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@en

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@nl

P1476

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

@en

P2093

Bert Schepens

http://www.w3.org/2001/XMLSchema#string

Michael Schotsaert

http://www.w3.org/2001/XMLSchema#string

Xavier Saelens

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of host adaptive immunity by hRSV proteins

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Respiratory syncytial virus infection in elderly and high-risk adults.

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

Function of the respiratory syncytial virus small hydrophobic protein.

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.

P304

203-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/IMT.15.11

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274088604

http://www.w3.org/2001/XMLSchema#string

P698

25804473

http://www.w3.org/2001/XMLSchema#string

P921

hydrophobicity

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

about

P2860

P2860

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921